|
1
|
Dalal M, Hentrich M, Stamatoullas-Bastard A, Zagadailov E, Gautam A, Way N, Cambron-Mellott M, Illidge T. CLINICAL OUTCOMES ASSOCIATED WITH THE TREATMENT OF NEWLY DIAGNOSED STAGE IV CLASSICAL HODGKIN LYMPHOMA IN PRACTICE SETTINGS IN FRANCE, GERMANY AND THE UNITED KINGDOM. Hematol Oncol 2019. [DOI: 10.1002/hon.167_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M.R. Dalal
- Global Outcomes Research & Epidemiology (Oncology); Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Cambridge United States
| | | | | | - E.A. Zagadailov
- Global Outcomes Research & Epidemiology (Oncology); Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Cambridge United States
| | - A. Gautam
- Global Outcomes Research & Epidemiology (Oncology); Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA; Cambridge United States
| | - N.A. Way
- Health Outcomes Practice; Kantar Health; San Mateo United States
| | | | - T.M. Illidge
- University of Manchester; Christie Hospital; Manchester United Kingdom
| |
Collapse
|